These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 691006)
1. Drugs derived from cannabinoids. 7. Tachycardia and analgesia structure-activity relationships in delta9-tetrahydrocannabinol and some synthetic analogues. Osgood PF; Howes JF; Razdan RK; Pars HG J Med Chem; 1978 Aug; 21(8):809-11. PubMed ID: 691006 [TBL] [Abstract][Full Text] [Related]
2. Structure--activity studies on tetrahydro- and hexahydrocannabinol derivatives. Skinner WA; Rackur G; Uyeno E J Pharm Sci; 1979 Mar; 68(3):330-2. PubMed ID: 423121 [TBL] [Abstract][Full Text] [Related]
3. delta9-Tetrahydrocannabinol and dimethylheptylpyran induced tachycardia in the conscious rat. Osgood PF; Howes JF Life Sci; 1977 Nov; 21(9):1329-36. PubMed ID: 927033 [No Abstract] [Full Text] [Related]
4. Marihuana-like activity of new synthetic tetrahydrocannabinols. Martin BR; Dewey WL; Harris LS; Beckner J Pharmacol Biochem Behav; 1975; 3(5):849-53. PubMed ID: 1208625 [TBL] [Abstract][Full Text] [Related]
5. Analgesic properties of the tetrahydrocannabinols, their metabolites, and analogs. Wilson RS; May EL J Med Chem; 1975 Jul; 18(7):700-3. PubMed ID: 1151992 [TBL] [Abstract][Full Text] [Related]
6. Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice. Varvel SA; Bridgen DT; Tao Q; Thomas BF; Martin BR; Lichtman AH J Pharmacol Exp Ther; 2005 Jul; 314(1):329-37. PubMed ID: 15831444 [TBL] [Abstract][Full Text] [Related]
7. Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. Winn M; Arendsen D; Dodge P; Dren A; Dunnigan D; Hallas R; Hwang K; Kyncl J; Lee YH; Plotnikoff N; Young P; Zaugg H J Med Chem; 1976 Apr; 19(4):461-71. PubMed ID: 817021 [TBL] [Abstract][Full Text] [Related]
8. Some 11-substituted tetrahydrocannabinols. Synthesis and comparison with the potent cannabinoid metabolites 11-hydroxytetrahydrocannabinols. Wilson RS; Martin BR; Dewey WL J Med Chem; 1979 Jul; 22(7):879-82. PubMed ID: 448686 [TBL] [Abstract][Full Text] [Related]
9. Pharmacology of some synthetic tetrahydrocannabinols. Pradhan SN Neurosci Biobehav Rev; 1984; 8(3):369-85. PubMed ID: 6095152 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and pharmacological evaluation of amino, azido, and nitrogen mustard analogues of 10-substituted cannabidiol and 11- or 12-substituted delta 8-tetrahydrocannabinol. Compton DR; Little PJ; Martin BR; Gilman JW; Saha JK; Jorapur VS; Sard HP; Razdan RK J Med Chem; 1990 May; 33(5):1437-43. PubMed ID: 2158563 [TBL] [Abstract][Full Text] [Related]
11. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice. Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914 [TBL] [Abstract][Full Text] [Related]
12. 9-Nor-9-hydroxyhexahydrocannabinols. Synthesis, Some behavioral and analgesic properties, and comparison with the tetrahydrocannabinols. Wilson RS; May EL J Med Chem; 1976 Sep; 19(9):1165-7. PubMed ID: 978681 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and pharmacological activity of some 9-substituted delta 8-tetrahydrocannabinol analogues. Robertson LR; Duffley RP; Razdan RK; Martin BR; Harris LS; Dewey WL J Med Chem; 1984 Apr; 27(4):550-2. PubMed ID: 6323713 [TBL] [Abstract][Full Text] [Related]
14. Acute and subacute interactions between delta9-tetrahydrocannabinol and other drugs in the rat. Pryor GT; Husain S; Mitoma C Ann N Y Acad Sci; 1976; 281():171-89. PubMed ID: 1071364 [No Abstract] [Full Text] [Related]
15. Influence of several anesthetic agents on the effect of delta9-tetrahydrocannabinol on the heart rate and blood pressure of the mongrel dog. Jandhyala BS; Buckley JP Eur J Pharmacol; 1977 Jul; 44(1):9-16. PubMed ID: 885163 [TBL] [Abstract][Full Text] [Related]
16. Task specificity of cross-tolerance between Delta9-tetrahydrocannabinol and anandamide analogs in mice. Wiley JL; Smith FL; Razdan RK; Dewey WL Eur J Pharmacol; 2005 Mar; 510(1-2):59-68. PubMed ID: 15740725 [TBL] [Abstract][Full Text] [Related]
17. AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol-Like Effects in Mice. Wiley JL; Marusich JA; Lefever TW; Antonazzo KR; Wallgren MT; Cortes RA; Patel PR; Grabenauer M; Moore KN; Thomas BF J Pharmacol Exp Ther; 2015 Sep; 354(3):328-39. PubMed ID: 26105953 [TBL] [Abstract][Full Text] [Related]
18. Assessment of driving capability through the use of clinical and psychomotor tests in relation to blood cannabinoids levels following oral administration of 20 mg dronabinol or of a cannabis decoction made with 20 or 60 mg Delta9-THC. Ménétrey A; Augsburger M; Favrat B; Pin MA; Rothuizen LE; Appenzeller M; Buclin T; Mangin P; Giroud C J Anal Toxicol; 2005; 29(5):327-38. PubMed ID: 16105257 [TBL] [Abstract][Full Text] [Related]
19. Effects of delta9-tetrahydrocannabinol and cannabinol in man. Karniol IG; Shirakawa I; Takahashi RN; Knobel E; Musty RE Pharmacology; 1975; 13(6):502-12. PubMed ID: 1221432 [TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships in man of cannabis constituents, and homologs and metabolites of delta9-tetrahydrocannabinol. Hollister LE Pharmacology; 1974; 11(1):3-11. PubMed ID: 4610598 [No Abstract] [Full Text] [Related] [Next] [New Search]